LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions
ContributorsYu, Kang; Davidson, Chelsea L; Wójtowicz, Agnieszka; Lisboa, Luiz; Wang, Ting; Airo, Adriana M; Villard, Jean; Buratto, Jeremie; Sandalova, Tatyana; Achour, Adnane; Humar, Atul; Boggian, Katia; Cusini, Alexia; Van Delden, Christian; Egli, Adrian; Manuel, Oriol; Mueller, Nicolas; Bochud, Pierre-Yves
Published inJournal of Clinical Investigation, vol. 128, no. 4, p. 1523-1537
Publication date2018
Abstract
Affiliation entities
Citation (ISO format)
YU, Kang et al. LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions. In: Journal of Clinical Investigation, 2018, vol. 128, n° 4, p. 1523–1537. doi: 10.1172/JCI96174
Main files (1)
Article (Published version)
Identifiers
- PID : unige:111074
- DOI : 10.1172/JCI96174
- PMID : 29528338
Journal ISSN0021-9738